13F-HR filed by TLS Advisors LLC
TLS Advisors LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 21 holding rows worth $20,289,000.
- Accession
- 0001768824-23-000002
- Filer
- CIK 1768824
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 21 entries on the cover page, a total value of $20,289,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $20,289,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-23033. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EQT CORP COM | 26884L109 | Stock | 150,800 | $5,102,000 | thousands, detected and multiplied | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 1,490,534 | $2,772,000 | thousands, detected and multiplied | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 124,024 | $2,282,000 | thousands, detected and multiplied | |
| META PLATFORMS INC CL A | 30303M102 | COM | 14,589 | $1,756,000 | thousands, detected and multiplied | |
| OMNIAB INC | 68218J103 | COM | 386,592 | $1,392,000 | thousands, detected and multiplied | |
| SILVERGATE CAP CORP CLASS A | 82837P408 | CL A | 79,795 | $1,388,000 | thousands, detected and multiplied | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 33,756 | $1,331,000 | thousands, detected and multiplied | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 125,731 | $1,034,000 | thousands, detected and multiplied | |
| Tesla Motors, Inc | 88160R101 | COM | 6,000 | $739,000 | thousands, detected and multiplied | |
| MEI PHARMA INC | 55279B202 | COM NEW | 2,010,285 | $490,000 | thousands, detected and multiplied | |
| F-STAR THERAPEUTICS INC | 30315R107 | COM | 54,298 | $343,000 | thousands, detected and multiplied | |
| NEBIUS GROUP N.V. | N97284108 | SHS CLASS A | 17,811 | $337,000 | thousands, detected and multiplied | |
| HOVNANIAN ENTERPRISES INC | 442487401 | CL A NEW | 6,472 | $272,000 | thousands, detected and multiplied | |
| ISHARES INC | 46434G780 | MSCI SINGPOR ETF | 13,600 | $255,000 | thousands, detected and multiplied | |
| AFFIMED N V | N01045108 | COM | 161,971 | $201,000 | thousands, detected and multiplied | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 250 | $180,000 | thousands, detected and multiplied | |
| NKARTA INC | 65487U108 | COMMON STOCK | 26,842 | $161,000 | thousands, detected and multiplied | |
| RANGE RES CORP COM | 75281A109 | Stock | 59,823 | $150,000 | thousands, detected and multiplied | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 89,403 | $52,000 | thousands, detected and multiplied | |
| NANO DIMENSION LTD | 63008G203 | SPONSORD ADS NEW | 22,000 | $51,000 | thousands, detected and multiplied | |
| KLUDEIN I ACQUISITION CORP | 49878L117 | *W EXP 07/08/202 | 10,000 | $1,000 | thousands, detected and multiplied |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001768824-23-000002 | this filing | 2023-02-14 | acceptance time not in the bulk data set |